Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005 - Concepedia

Concepedia

Publication | Open Access

Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005

DOI Full Paper Access

157

Citations

40

References

2015

Year

Yongli Ji, Cathryn Rankin, Steven M. Grunberg, Andy Sherrod, Jamshid Ahmadi, Jeannette J. Townsend, Lynn G. Feun, Ruth K. Fredericks, Christy Russell, Fairooz F. Kabbinavar,

Journal of Clinical Oncology

Abstract

Long-term administration of mifepristone was well tolerated but had no impact on patients with unresectable meningioma.

References

	Year	Citations

Page 1